Pulmonary Hypertension

CTEPH May Improve With Extracorporeal Membrane Oxygenation After PEA

By

Pulmonology Advisor Contributing Writer

Extracorporeal membrane oxygenation may be beneficial for patients with thromboembolic pulmonary hypertension after pulmonary endarterectomy for cardiac and respiratory complications.

Subcutaneous Delivery System for Treprostinil Cleared by FDA

By

Steve Duffy Digital Content Editor

The FDA has cleared the Unity Subcutaneous Delivery System for Remodulin (treprostinil) Injection, also known as the RemUnity system.

Beraprost May Improve Cardiopulmonary and Exercise Capacity in PH-HFrEF

By

Pulmonology Advisor Contributing Writer

The addition of beraprost to the usual treatment of pulmonary hypertension due to left ventricular systolic dysfunction may improve cardiopulmonary hemodynamic and exercise capacity.

Balloon Pulmonary Angioplasty Safe for Kidney Function in CTEPH

By

Pulmonology Advisor Contributing Writer

Balloon pulmonary angioplasty therapy improves pulmonary and systemic hemodynamics, with positive effects on renal function.

Addressing Barriers to Physical Exercise in Pulmonary Hypertension

By

Pulmonology Advisor Contributing Writer

Patients with pulmonary hypertension cite lack of energy, lack of self-discipline, and lack of interest as barriers to increasing their levels of physical activity and exercise.

Combined Automated 3D Volumetry and Echocardiography Detects PH

By

Brandon May

Investigators used computed tomography pulmonary angiography to evaluate the diagnostic accuracy of automated 3D volumetry of central pulmonary arteries for suspected pulmonary hypertension alone and in combination with echocardiography.

Six Radiologic Parameters May Predict CTEPH in Acute Pulmonary Embolism

By

Brandon May

Expert radiologists can accurately identify patients who will later be diagnosed with CTEPH by evaluating the computed tomography pulmonary angiogram scan performed in the setting of suspected acute pulmonary embolism using 6 standardized radiologic parameters.

Similar Poor Survival Outcomes in Lung-Disease-Associated PH and Idiopathic PAH

By

Brandon May

Despite less severe right ventricle dilation, tricuspid regurgitation, and degree of pulmonary hypertension (PH), researchers found that patients with lung disease-associated PH have equally poor survival compared with those with idiopathic PAH.